As these metabolic processes are also involved in NLRP3 inflammasome activation [206, 324–326], AMPK dysfunction may further exacerbate neuroinflammatory reponses in AD by disrupting metabolic homeostasis. The gene discussed is NLRP3; the disease is Alzheimer disease.